Effects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometrium

Human Reproduction

Volumn 16, Issue 10, 2001, Pages 2103-2108

  Maruo, T ^a   Laoag Fernandez, J B ^a   Pakarinen, P ^b   Murakoshi, H ^a   Spitz, I M ^c   Johansson, E ^d  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Institute of Hormone Research   (Israel)

^d POPULATION COUNCIL   (United States)

Author keywords

Apoptosis; Endometrium; Levonorgestrel releasing intrauterine system; Proliferation

Indexed keywords

AVIDIN; BIOTIN; CYCLINE; FAS ANTIGEN; LEVONORGESTREL; PROTEIN BCL 2;

ADENOMYOSIS; ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG EFFICACY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; IMMUNOPEROXIDASE STAINING; INTRAUTERINE CONTRACEPTIVE DEVICE; MENORRHAGIA; MENSTRUAL CYCLE; NICK END LABELING; OVARY FOLLICLE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STROMA CELL;

EID: 0034784709     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/16.10.2103     Document Type: Article

References (34)

1. The levonorgestrel intrauterine system in the management of menorrhagia
2. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding
3. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device
4. Levonorgestrel-releasing intrauterine device for the treatment of menometrorrhagia in the woman on hemodialysis
5. Detection of apoptosis in human endometriotic tissues
6. Randomized controlled trial exists on levonorgestrel intrauterine system for menorrhagia
7. A novel protein domain required for apoptosis
8. The polypeptide encoded by the cDNA for the human cell surface antigen Fas can mediate apoptosis
9. Apoptosis and Bcl-2 expression in normal human endometrium, endometriosis and adenomyosis
10. Morphological and functional changes in human endometrium following intrauterine levonorgestrel delivery
11. Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia
12. Apoptosis in the human uterine endometrium during the menstrual cycle
13. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
14. Levonorgestrel-releasing intrauterine device
15. Immunohistochemical localization of epidermal growth factor receptor and myc oncogene product in the human placenta: Implication for trophoblast proliferation and differentiation
16. Apoptosis and Ko-67 expression in adenomyotic lesions in the corresponding eutopic endometrium
17. Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone
18. The Fas death factor
19. Deregulated Bcl-2 protein expression selectively prolongs survival of growth factor-deprived hematopoietic cell lines
20. Cyclic Bcl-2 gene expression in human uterine endometrium during menstrual cycle
21. The effect of local intrauterine levonorgestrel administration on endometrial thickness and uterine blood circulation
22. Oncogene and tumour suppressor gene products during trophoblast differentiation in the first trimester
23. Bcl-2 and the regulation of programmed cell death
24. Bcl-2, Fas and caspase 3 expression in endometrium from levonorgestrel implant users with and without breakthrough bleeding
25. Endometrial morphology during the longterm use of levonorgestrel-releasing IUD
26. Health during prolonged use of levonorgestrel 20 μg/d and the copper TCu 380 Ag intrauterine contraceptive devices: A multicenter study
27. Gynecological aspects of levonorgestrel-releasing intrauterine system
28. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
29. Apoptosis in human endometrial and endometriotic tissues
30. Differential expression of the members of the Bcl-2 gene family in proliferative and secretory human endometrium: Glandular epithelial cell apoptosis is associated with increased expression of bax
31. Apoptosis and apoptosis-related proteins in human endometrium
32. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis
33. Fas ligand and Bcl-2 expression in human endometrium during the menstrual cycle
34. The effect of levonorgestrel-releasing intrauterine device on human endometrial oestrogen and progesterone receptors after 1 year of use